| Authors: |
Sung ML; From the Pain Research, Informatics, Multimorbidities and Education Center of Innovation, VA Connecticut Healthcare System, West Haven, CT (MLS, ACB); Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT (MLS, DAF, EJE); Section of General Internal Medicine, Yale School of Medicine, New Haven, CT (MLS, ACB, DAF, EJE); Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY (DB, FRL); Division on Substance Use Disorders, New York State Psychiatric Institute, New York, NY (DB, FRL); Consortium on Substance Use and Addiction, Social Science Research Institute, Pennsylvania State University, University Park, PA (BFH); College of Education, Pennsylvania State University, University Park, PA (BFH); American Academy of Addiction Psychiatry, East Providence, RI (KC-W); VA Boston Healthcare System, Boston, MA (MAD); Department of Psychiatry, Boston University Medical Center, Boston, MA (MAD); Addiction Technology Transfer Center Network Coordinating Office, University of Missouri, Kansas City, Kansas City, MO (HH); Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA (PJJ); Center for Health Enhancement Systems Studies, University of Wisconsin, Madison, WI (TM); Department of Emergency Medicine, Yale School of Medicine, New Haven, CT & Yale School of Public Health, New Haven, CT (DAF); Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT (EJE)., Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Hagle H, Joudrey PJ, Molfenter T, Levin FR, Fiellin DA, Edelman EJ |
